Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA leadership in clinical trial computer simulation urged in IAF report.

Executive Summary

FDA LEADERSHIP IN CLINICAL TRIAL COMPUTER SIMULATION URGED in the Institute for Alternative Future's "Clinical Development 2005" report discussed at a Capitol Hill briefing July 18. "Advances in computer simulation can contribute significantly to the process of clinical development," the report declares. Placing FDA in a leadership role to develop the concept "would be a powerful leveraging strategy that would position simulation as a new mechanism in clinical development," the report states.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030532

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel